Your fact-checks will appear here
manages a portfolio of companies aimed at discovering disease‑modifying therapeutics for dementia and has backed roughly 19 companies, several of which are pursuing ‑focused programs, but the publicly...
The Dementia Discovery Fund (DDF), managed by SV Health Investors, has built a multi‑dozen portfolio since 2015 and reports that a substantial fraction of its investments have reached clinical develop...
The available reporting documents the Dementia Discovery Fund (DDF) as a venture capital vehicle launched in 2015 to finance translational dementia research and lists its backers and fundraising miles...
Venture-capital (VC) models have become a major engine financing early-stage dementia therapeutics, praised for mobilizing large sums and industry expertise but criticized for pressure to produce comm...